Non trouvé

8Mo·

Good morning,

What do you think of this company? I have just joined the company as I find AI in healthcare exciting. The company also has a market capitalization of just €100 million. I'll start with 50 shares today and see what happens. My goal is to have 500 shares and hold them for at least 1 year.

Best regards

https://healwell.ai

13.05

AID

Healwell Al

Acheté x50 à 1,04 €

52,00 €

healwell.aiHEALWELL AI: Preventative Health Care | AI Clinical Co-Pilot

19 Commentaires

TomTurboInvest@TomTurboInvest

8Mo

Canadian penny stock, I don't think I need more info 😉
EBITDA -9mio, cash flow-7mio good luck😂

•

McCrispy@McCrispy

8Mo

@TomTurboInvest Doesn't every startup have negative balance sheets?

••

TomTurboInvest@TomTurboInvest

8Mo

@McCrispy Absolutely, but start-ups are rarely already on the stock exchange at this stage and raise their capital elsewhere.
Have you ever looked into the low requirements and regulations of the CSE or NEO? That's the reason for the "infamous" Canadian penny stocks...
It's just a game of chance, there are too many shady companies that want to take money out of the pockets of small investors. But maybe you'll be lucky and the well-known portals will push the stock and you'll get in and out of the Christmas tree chart early enough 🤷🏽‍♂️

•

Smudo@Smudeo

8Mo

@TomTurboInvest well, with an investment of 1/3 of an hour's pay, he could have invited a girl to @McCrispy for a snack, you'd certainly get more out of it afterwards.

•

vbr@vbr

4Mo

@TomTurboInvest

•

TomTurboInvest@TomTurboInvest

3Mo

@vbr a beautiful Christmas tree chart, like something out of a textbook 😂
With good timing, you can definitely profit from it, but most people get in too late and get out too late...

••

Brody@Brody

8Mo

Don't know the company. AI in healthcare is not a new topic. Many large companies are already involved (NVIDIA, Alphabet, Amazon...). It would be interesting to know how Healwell differentiates itself from other companies.

•

McCrispy@McCrispy

8Mo

@Brody healwell is building its own platform that specializes in diagnosing diseases faster and more accurately, thereby reducing the mortality rate due to late diagnoses

••

Basti@Emirox

7Mo

If you follow the company and look at the goals and activities, it can be exciting.

•

Ludaaa7@Ludaaa7

8Mo

Le commentaire a été supprimé

Ludaaa7@Ludaaa7

8Mo

Achsooo... at 50€ you can of course also let it run and hope for the explosion :-D

••

Utilisateur supprimé

8Mo

Le commentaire a été supprimé

McCrispy@McCrispy

8Mo

@Michael-official The company is relatively new and focuses on using AI to recognize and cure diseases more quickly. To this end, the company is developing a platform that evaluates typical disease patterns, for example, in order to provide an accurate diagnosis with a low error rate

••

Das Portfoliopferd@Portfoliopferd

8Mo

@McCrispy How does the platform work?

••

Kevin E.@KevinE

8Mo

@Portfoliopferd probably not at all 🤷‍♂️

••

TomTurboInvest@TomTurboInvest

8Mo

@[McCrispy](McCrispy) Who would be the target group for such a platform?

The Pfizer's, Merck's and Co of this world, who develop drugs and bring them to market, have collected this data themselves in the course of their research and test studies and also make it available to their customers such as doctors and hospitals.
The question for me is who should rely on results and recommendations from such a third-party platform? And where does a newcomer get this sensitive data from? But I'm not an expert in this area either...

••

McCrispy@McCrispy

8Mo

@TomTurboInvest I trust the company to deliver on the promises they make and the platform they offer. The business model convinces me

•

TomTurboInvest@TomTurboInvest

8Mo

@McCrispy well then all the best for the trade - keep us posted! I'm out of CA*** pennystocks.

••

ynnxs@ynnxs

2Mo

@McCrispy I am also convinced and on board 😄✌🏻

••